Elevation Wealth Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.1K Buy
134
+29
+28% +$11.6K 0.01% 379
2026
Q2
$40.6K Buy
105
+90
+600% +$33.4K 0.01% 360
2026
Q1
$4.4K Sell
15
-4
-21% -$1.31K ﹤0.01% 741
2025
Q4
$6.67K Buy
19
+7
+58% +$2.37K ﹤0.01% 564
2025
Q3
$3.88K Buy
+12
New +$3.73K ﹤0.01% 525
2025
Q2
– Hold
0
– – – 480
2025
Q1
– Hold
0
– – – 488
2024
Q4
– Hold
0
– – – 495
2024
Q3
– Hold
0
– – – 471
2024
Q2
– Hold
0
– – – 500
2024
Q1
– Hold
0
– – – 470
2023
Q4
– Hold
0
– – – 438
2023
Q3
– Hold
0
– – – 339
2023
Q2
– Hold
0
– – – 352
2023
Q1
– Hold
0
– – – 347

Other funds holding ELV

Elevation Wealth Partners's ELV Position: Q3 2026 in Review

Elevation Wealth Partners increased its Elevance Health (ELV) stake by 28% in Q3 2026, buying an estimated $11.6K and bringing the position to 134 shares worth $52.1K. The position accounts for 0.01% of the portfolio, ranked #379.

Elevation Wealth Partners first reported a position in ELV in Q3 2025 and has held it in 5 quarters since. 64 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • Elevation Wealth Partners held 134 shares of Elevance Health worth $52.1K as of Q3 2026.
  • Elevation Wealth Partners bought 29 Elevance Health shares in Q3 2026, an estimated $11.6K.
  • Elevance Health made up 0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #379 holding.
  • Elevation Wealth Partners first reported a position in Elevance Health in Q3 2025 and has held it in 5 quarters since.
  • 64 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.